药源性高血压
摘要
药源性高血压是继发性高血压的重要原因之一，充分认识和积极预防药源性高血压十分必要。本文就临床常见导致药源性高血压的药物及其诊断与处理综合近年文献作一综述。
出处
《国际泌尿系统杂志》
2013年第1期143-144,F0003,F0004,共4页
International Journal of Urology and Nephrology
参考文献34
-
1Grossman E, Messerli FH. Drug - induced hypertension : an unap- preciated cause of secondary hypertension. Am J Med,2012,125 (1): 14-22.
-
2Elliott WJ. Drug interactions and drugs that affect blood pressure. J Clin Hypertens, 2006, 8(10) : 731 -737.
-
3Gonzalez - Paeheco FR, Deudero JJ, Castellanos MC, et al. Mechanisms of endothelial response to oxidative aggression: pro- tective role of autologous VEGF and induetion of VEGFR2 by H202. Am J Physiol Heart Cite Physiol, 2006, 291 (3) : H1395 - HI401.
-
4Kappers MH, van Esch JH, Sluiter W, et al. Hypertension in- duced by the tyrosine kinase inhibitor sunitinib is associated with increased circulating endothelin - 1 levels. Hypertension, 2010, 56(4) : 675 -681.
-
5Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic eolorectal cancer. N Engl J Med, 2004, 350(23) : 2335 -2342.
-
6Shih T, Lindley C. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther, 2006, 28 (11) : 1779 - 1802.
-
7lzzedine H, Ederhy S, Goldwasser F, et al. Management of hyper- tension in angiogenesis inhibitor - treated patients. Ann Oncol, 2009, 20(5) : 807 -815.
-
8Lee K, Yang H, Lim H, et al. A prospective study of blood pres- sure and intraocular pressure changes in hypertensive and nonhy- pertensive patients after intravitreal bevacizumab injection. Retina, 2009, 29(10) : 1409 - 1417.
-
9Sheybani A, Kymes S, Schlief S, et al. Vascular events in patients with age - related macular degeneration treated with intraocular be- vacizumab. Retina, 2009, 29(10) : 1404 - 1408.
-
10Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear- cell renal -cell carcinoma. N Engl J Med, 2007, 356 (2) : 125 - 134.
-
1王振坤.药源性高血压[J].健康博览,1997,0(1):7-7.
-
2徐艳花.药源性高血压的致病机理及预防[J].中国医药指南（学术版）,2007,5(09S):86-87.
-
3魏开敏.当心药源性高血压[J].解放军健康,2002(3):35-35.
-
4金仲品.药源性高血压的发生机理[J].临床荟萃,1992,7(7):308-309.
-
5崔淑兰,陈垦,张廷杰.药源性高血压[J].心血管病学进展,1995,16(1):9-12. 被引量：2
-
6鄢艳丽,雷招宝.药源性高血压及其防治[J].临床合理用药杂志,2009,2(14):113-114. 被引量：5
-
7马强.警惕药源性高血压[J].药物与人,2000,13(1):32-32.
-
8杜文民.药源性高血压的诊断与治疗[J].上海医药,2011,32(8):383-386. 被引量：3
-
9郑丽容,罗群,刘华珍.可致高血压的抗肿瘤药[J].临床医药实践,2009,18(10):766-767. 被引量：1
-
10贾世新.68例老年药源性高血压的临床分析[J].世界最新医学信息文摘,2015,15(68). 被引量：1
